{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:29:00Z","timestamp":1781202540736,"version":"3.54.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T00:00:00Z","timestamp":1470182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0159925","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T13:44:28Z","timestamp":1470231868000},"page":"e0159925","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-5828","authenticated-orcid":false,"given":"T.","family":"Rodrigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Caminero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Jim\u00e9nez-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ruiz-Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cayl\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Working Group of the Integrated Programme of Tuberculosis Research","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJM197603112941104","article-title":"Measuring the quality of medical care","volume":"294","author":"DD Rutstein","year":"1976","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/S1135-57272003000200002","article-title":"Mortalidad y tuberculosis: an\u00e1lisis por causas m\u00faltiples en la comunidad de Madrid (1991\u20131998)","volume":"77","author":"M Ordob\u00e1s","year":"2003","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"ref3","unstructured":"WHO. Global Tuberculosis Report 2015. WHO Library. ISBN 978 924 1565059. Geneva, 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/191102\/1\/9789241565059_eng.pdf?ua=1\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/191102\/1\/9789241565059_eng.pdf?ua=1<\/ext-link>."},{"key":"ref4","first-page":"308","article-title":"Estimating tuberculosis case mortality in England and Wales, 2001\u20132002","volume":"12","author":"JP Crofts","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref5","unstructured":"ECDC Surveillance Report 2014. Annual Epidemiological Record: Respiratory tract infection\u2014tuberculosis. Stockholm: ECDC; 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/Respiratorytract-infections-annual-epidemiological-report-2014.pdf\" xlink:type=\"simple\">http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/Respiratorytract-infections-annual-epidemiological-report-2014.pdf<\/ext-link>."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1183\/09031936.00131107","article-title":"Risk factors for death among tuberculosis cases: analysis of European surveillance data","volume":"31","author":"N Lefebvre","year":"2008","journal-title":"Eur Respir J"},{"key":"ref7","article-title":"Drug-Resistant Tuberculosis: Old\u2013Disease\u2014New Treat","year":"2013"},{"issue":"5","key":"ref8","first-page":"542","article-title":"Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors","volume":"10","author":"TR Sterling","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2334-9-95","article-title":"Deaths among tuberculosis cases in Shanghai, China: who is at risk?","volume":"9","author":"X Shen","year":"2009","journal-title":"BMC InfectiousDiseases"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"e73501","DOI":"10.1371\/journal.pone.0073501","article-title":"Adherence to Tuberculosis Treatment, Sputum Smear Conversion and Mortality: A Retrospective Cohort Study in 48 Rwandan Clinics","volume":"8","author":"FR Kayigamba","year":"2013","journal-title":"PLoS ONE"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/ije\/dyn089","article-title":"Demographic, health services and socioeconomic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico","volume":"37","author":"JC N\u00e1jera-Ortiz","year":"2008","journal-title":"Int J Epidemiol"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"e23715","DOI":"10.1371\/journal.pone.0023715","article-title":"Initial Presentations Predict Mortality in Pulmonary Tuberculosis Patients\u2014A Prospective Observational Study","volume":"6","author":"J-Y Feng","year":"2011","journal-title":"PLoS ONE"},{"issue":"No. 2","key":"ref13","article-title":"Differential Morbidity and Mortality Patterns of Pulmonary Tuberculosis","volume":"Volume 3","author":"N Ahamd","year":"2012","journal-title":"Review of Global Medicine and Healthcare Research"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1186\/1471-2458-11-921","article-title":"The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India","volume":"11","author":"S Jonnalagada","year":"2011","journal-title":"BMC Public Health"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0019-5359.53163","article-title":"Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course","volume":"63","author":"G Pardeshi","year":"2009","journal-title":"Indian J Med Sci"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Farga V, Caminero JA. Tuberculosis (p\u00e1g: 36 y 347). Editorial Mediterr\u00e1neo (3\u00aa Edici\u00f3n). Santiago de Chile, 2011. doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1016\/j.tube.2010.11.008\" xlink:type=\"simple\">10.1016\/j.tube.2010.11.008<\/ext-link> 21147037","DOI":"10.1016\/j.tube.2010.11.008"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jech.2008.077560","article-title":"Tuberculosis recurrence and its associated risk factors among successfully treated patients","volume":"63","author":"JP Millet","year":"2009","journal-title":"J Epidemiol Community Health"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2334-10-54","article-title":"Mortality among patients with tuberculosis requiring intensive care: a retrospective cohort study. Silva et al","volume":"10","author":"DR Silva","year":"2010","journal-title":"BMC Infectious Diseases"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"e20755","DOI":"10.1371\/journal.pone.0020755","article-title":"Assessing Tuberculosis Case Fatality Ratio: A Meta-Analysis","volume":"6","author":"M Straetemans","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"ref20","first-page":"246","article-title":"Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung","volume":"15","author":"YJ Ryu","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/apc.2009.0030","article-title":"HIV-Specific Health Care Utilization and Mortality among Tuberculosis = HIV Coinfected Persons","volume":"23","author":"LB Gadkowski","year":"2009","journal-title":"AIDS Patient Care"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1086\/588292","article-title":"Risk Factors and Mortality Associated with Default from Multidrug-Resistant Tuberculosis Treatment","volume":"46","author":"MF Franke","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1086\/424676","article-title":"Outcome of HIV-Associated Tuberculosis in the Eraof Highly Active Antiretroviral Therapy","volume":"190","author":"K Dheda","year":"2004","journal-title":"JID"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.arbres.2014.06.001","article-title":"Resistencia a f\u00e1rmacos antituberculosos de primera l\u00ednea en Espa\u00f1a durante 2010\u20132011. Estudio RETUBES","volume":"51","author":"R Blanquer","year":"2015","journal-title":"Arch Bronconeumol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-11-1","article-title":"Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis","volume":"11","author":"P Nahid","year":"2011","journal-title":"BMC Infectious Diseases"},{"key":"ref26","unstructured":"WHO. TB imp. act measurement. Policy and recommendations for how to assess the epidemiological burden of TB and the impact of TB control (Stop TB policy paper; no. 2). ISBN 978 92 4 159 882 8. Geneva 2009."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(06)68392-X","article-title":"WHO\u2019s new Stop TB strategy","volume":"367","author":"MC Raviglioni","year":"2006","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0019-5359.53163","article-title":"Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course","volume":"63","author":"G Pardeshi","year":"2009","journal-title":"Indian J Med Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/rccm.200401-095OC","article-title":"Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy","volume":"170","author":"R M Jasmer","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref30","unstructured":"Therneau T, Lumley T. original R port by Thomas Lumley. Survival: Survival analysis, including penalised likelihood. R package version 2.35\u20137. 2009. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/CRAN.R-project.org\/package=survival\" xlink:type=\"simple\">http:\/\/CRAN.R-project.org\/package=survival<\/ext-link>."},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"e25315","DOI":"10.1371\/journal.pone.0025315","article-title":"Predictors of Death among Patients Who Completed Tuberculosis Treatment: A Population-Based Cohort Study","volume":"6","author":"JP Millet","year":"2011","journal-title":"PLoS ONE"},{"issue":"11","key":"ref32","first-page":"e1001347","article-title":"Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB\/RIF: A Dynamic Simulation and Economic Evaluation","volume":"9","author":"NA Menzies","year":"2012","journal-title":"PLoS ONE"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"JA Caminero","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MCP.0000000000000045","article-title":"Tuberculosis: Clinical Trials and New Drug Regimens","volume":"20","author":"Y Kwon","year":"2014","journal-title":"Curr Opin Pulm Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0159925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T23:56:33Z","timestamp":1568246193000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0159925"}},"subtitle":[],"editor":[{"given":"Sanjay Haresh","family":"Chotirmall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0159925","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]}}}